Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets
Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Fluphenazine Hydrochloride Tablets 1 mg, 2.5 mg, 5 mg, and 10 mg. The reference listed drug (RLD) of Zydus Cadila’ Fluphenazine Hydrochloride Tablets is Prolixin Tablets, which are indicated for the […]